Author:
Brison Caileen M.,Mullen Steven M.,Wuerth Michelle E.,Podolsky Kira,Cook Matthew,Herman Jacob A.,Walter Justin D.,Meeks Shannon L.,Spiegel P. Clint
Publisher
Public Library of Science (PLoS)
Reference62 articles.
1. The future of plasma-derived clotting factor concentrates;WK Hoots;Haemophilia: the official journal of the World Federation of Hemophilia,2001
2. Purity of factor VIII product and incidence of inhibitors in previously untreated patients with haemophilia A;EP Mauser-Bunschoten;Haemophilia: the official journal of the World Federation of Hemophilia,2001
3. Incidence of inhibitors in haemophilia A patients—a review of recent studies of recombinant and plasma-derived factor VIII concentrates;I Scharrer;Haemophilia: the official journal of the World Federation of Hemophilia,1999
4. A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A;GL Bray;The Recombinate Study Group. Blood,1994
5. Inhibitor development in previously untreated patients with hemophilia A: a prospective long-term follow-up comparing plasma-derived and recombinant products;W Kreuz;Seminars in thrombosis and hemostasis,2002
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献